+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Ablation Technology Market Report and Forecast 2024-2032

  • PDF Icon


  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895173
The global ablation technology market value was USD 5.7 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 9.9% during the forecast period of 2024-2032 to achieve a value of USD 13.2 billion by 2032.

Ablation Technology: Introduction

Ablation technology refers to a medical procedure or industrial process that involves the removal or destruction of material, typically through the application of energy, such as heat, radiofrequency, laser, or electrical energy. The goal of ablation is to target and remove or alter tissue or substances in a controlled and precise manner, without the need for traditional surgical incisions.

There are some common applications of ablation technology including medical ablation, cardiac ablation, cancer treatment, dermatological ablation, industrial ablation, ablation in aerospace, and ablation in geology.

The choice of ablation technology depends on the specific application and the desired outcome. It is often preferred for its minimally invasive nature, reduced risk compared to traditional surgery, and potential for quicker recovery times. However, the success of ablation procedures relies on precise targeting and monitoring to ensure that only the intended tissue or material is affected.

Key Trends in the Global Ablation Technology Market

Here are some key trends running in the global ablation technology market:

  • Technological Advancements: Ablation technologies are continuously evolving, with ongoing research and development efforts aimed at improving the precision, effectiveness, and safety of ablation procedures. Advancements in energy sources, imaging guidance systems, and catheter technologies are notable trends.
  • Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures across various medical specialties, including cardiology, oncology, and gynecology. Ablation technologies play a crucial role in enabling less invasive treatment options and reducing patient discomfort and recovery times.
  • Expanding Applications: The use of ablation technology is expanding beyond traditional applications. For example, it is being used to treat a wider range of cardiac arrhythmias, different types of cancer, and conditions like chronic pain and uterine fibroids.
  • Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, such as atrial fibrillation, cancer, and chronic pain disorders, is driving the demand for ablation technologies. These technologies offer an alternative or complementary approach to conventional treatments.
  • Personalized Medicine: There is a trend toward personalized medicine in healthcare, and ablation procedures are no exception. Physicians are increasingly tailoring ablation treatments to individual patient characteristics, which can improve outcomes.

Global Ablation Technology Market Segmentations

Market Breakup by Technology

  • Radiofrequency Devices
  • Laser/Light Ablation
  • Ultrasound Devices
  • Cryoablation Devices
  • Other Devices

Market Breakup by Applications

  • Cancer Treatment
  • Cardiovascular Disease Treatment
  • Ophthalmologic Treatment
  • Gynecological Treatment
  • Urological Treatment
  • Cosmetic Surgery
  • Others

Market Breakup by End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Ablation Technology Market Scenario

  • Market Growth: The ablation technology market is experiencing steady growth, driven by the increasing prevalence of chronic diseases, the adoption of minimally invasive procedures, and advancements in technology.
  • Cardiac Ablation: Within the medical field, cardiac ablation for the treatment of cardiac arrhythmias, particularly atrial fibrillation, is a prominent application. The market for cardiac ablation is expanding due to the rising incidence of atrial fibrillation and the development of more advanced ablation techniques.
  • Cancer Treatment: Ablation technologies are being increasingly used in the treatment of various types of cancer, including liver, lung, and kidney cancers. This is driven by the need for less invasive alternatives to surgery and the desire to improve patient outcomes.
  • Technological Advancements: Ongoing technological advancements in energy sources, catheter designs, and imaging guidance systems are enhancing the precision and effectiveness of ablation procedures. Innovations such as robotic-assisted ablation are gaining traction.
  • Minimally Invasive Procedures: The shift towards minimally invasive medical procedures across various medical specialties is boosting the demand for ablation technology. Patients and healthcare providers prefer these less invasive options for reduced patient discomfort and faster recovery times.

Global Ablation Technology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

  • Abbott
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation,
  • BTG plc
  • Conmed Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Olympus Corporation
  • Smith & Nephew PLC
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ablation Technology Market Overview
3.1 Global Ablation Technology Market Historical Value (2017-2023)
3.2 Global Ablation Technology Market Forecast Value (2024-2032)
4 Global Ablation Technology Market Landscape
4.1 Global Ablation Technology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ablation Technology: Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Applications
5 Global Ablation Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ablation Technology Market Segmentation
6.1 Global Ablation Technology Market by Technology
6.1.1 Market Overview
6.1.2 Radiofrequency Devices
6.1.3 Laser/Light Ablation
6.1.4 Ultrasound Devices
6.1.5 Cryoablation Devices
6.1.6 Other Devices
6.2 Global Ablation Technology Market by Applications
6.2.1 Market Overview
6.2.2 Cancer Treatment
6.2.3 Cardiovascular Disease Treatment
6.2.4 Ophthalmologic Treatment
6.2.5 Gynecological Treatment
6.2.6 Urological Treatment
6.2.7 Cosmetic Surgery
6.2.8 Others
6.3 Global Ablation Technology Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Ambulatory Surgical Centers
6.3.4 Others
6.4 Global Ablation Technology Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Ablation Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ablation Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ablation Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Ablation Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ablation Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 AngioDynamics, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 AtriCure, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Boston Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 BTG plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Conmed Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Johnson & Johnson
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtronic PLC
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Olympus Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Smith & Nephew PLC
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • Abbott
  • AngioDynamics Inc.
  • AtriCure Inc.
  • Boston Scientific Corporation
  • BTG plc
  • Conmed Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Olympus Corporation
  • Smith & Nephew PLC